Exercise after chemo: new trial tests if running and walking can keep colorectal cancer at bay
NCT ID NCT03822572
First seen Jun 26, 2026 · Last updated Jul 23, 2026 · Updated 2 times
Summary
This study tests whether a structured endurance exercise program, like walking or cycling, after finishing chemotherapy can help prevent colorectal cancer from returning. About 92 patients who have completed adjuvant chemotherapy will be randomly assigned to either an exercise program or their usual physical activity. Researchers will track how long they live without cancer coming back and overall survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- endurance exercise program
- What this could lead to
- If it works, this could show that a structured exercise program after chemotherapy helps prevent cancer from coming back and improves survival.
- What could go wrong
- This is a small, early-stage trial with only 92 participants, so results may not apply to everyone. Previous studies on exercise after chemotherapy have had mixed results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BKH Kufstein
Kufstein, Tyrol, 6330, Austria
-
Hospital BHS Linz, Coop. Study Group
Linz, Upper Austria, 4010, Austria
-
KH St. Josef Braunau
Braunau am Inn, Upper Austria, 5280, Austria
-
Kepler Universitätsklinikum Linz
Linz, Upper Austria, 4020, Austria
-
Klinikum Wels-Grieskirchen
Wels, Upper Austria, 4600, Austria
-
LKH Salzburg-PMU, UNiv. KLinik f. Innere Med III
Salzburg, State of Salzburg, 5020, Austria
-
Med. Univ. Graz
Graz, Styria, 8036, Austria
-
Pyhrn-Eisenwurzen Klinikum Steyr
Steyr, Upper Austria, 4400, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who will survive a bowel surgery leak?
- Can a Two-Drug attack shrink Hard-to-Treat colorectal tumors?
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- One simple score to rate colorectal cancer surgery quality?
- A mobile app aims to turn health awareness into action — a trial puts it to the test
- Can a walking routine alter cancer biomarkers? new trial investigates